| ID | 10419 |
| Vaccine Name | GII.4 P particles |
| Disease Name | Norovirus Infection |
| Disease Classification | Gastrointestinal |
| Virus Name | Norovirus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Virus like particle |
| Vaccine Status | Preclinical |
| Manufacturer | Cincinnati Children’s Hospital Medical Center |
| Year of Manufacturing | NA |
| Manufacturing Country | USA |
| Age | NA |
| Dosage | NA |
| Administration Route | Intranasal |
| Adjuvant | NA |
| Target Strain | P particles derived from HuNoV VP1 |
| Description | NA |
| Approving Organisation | NA |
| Collaborating Organisation | Southern Medical University, Virginia Polytechnic Institute and State University |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NA |
| Reference Link | https://www.mdpi.com/2076-393X/9/7/732/htm |
| Additional Links | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851174/
|